Search results for "Heart failure"
Beta-blockers associated with worse outcomes in new PAH
Death or hospitalization due to right-heart failure or syncope was more likely in patients who received beta-blockers after a new pulmonary arterial hypertension (PAH) diagnosis, especially if they had no cardiovascular comorbidities, a retrospective Polish study found.
https://immattersacp.org/weekly/archives/2024/11/19/2.htm
19 Nov 2024
Examining cost effects of ‘skinny-label’ generics
A federal ruling over a patent dispute could lead to long-term effects on health care spending in the United States, a recent study indicated.
https://immattersacp.org/archives/2024/11/examining-cost-effects-of-skinny-label-generics.htm
1 Nov 2024
MKSAP Quiz: Evaluation for heart failure
A 78-year-old woman is evaluated for a 3-month history of heart failure with reduced ejection fraction (ejection fraction, 20%). She has stable dyspnea when walking up stairs but has no other symptoms. Following a physical exam, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2024/10/22/3.htm
22 Oct 2024
Wearable sensor reduces heart failure rehospitalization, industry study finds
A temporary wearable device plus additional remote monitoring reduced heart failure readmissions by 38% among high-risk patients, a manufacturer's trial found.
https://immattersacp.org/weekly/archives/2024/10/15/4.htm
15 Oct 2024
When the doctor will (not) see you now
For many Americans, it is difficult to see a physician for an acute symptom, and almost impossible to get a primary care appointment for routine care in a reasonable amount of time.
https://immattersacp.org/archives/2024/11/when-the-doctor-will-not-see-you-now.htm
1 Nov 2024
MRAs appear effective for heart failure across the range of ejection fractions
Steroidal mineralocorticoid receptor antagonists (MRAs) (e.g., spironolactone and eplerenone) reduced risk for cardiovascular death or heart failure hospitalization in patients with heart failure and reduced ejection fraction (EF), while nonsteroidal MRAs (e.g., finerenone) seemed beneficial in those with mildly reduced or preserved EF, an individual-patient level meta-analysis found.
https://immattersacp.org/weekly/archives/2024/09/10/4.htm
10 Sep 2024
Treating obesity as a disease
Obesity stems from genetics and environmental factors, but bias by physicians and the public may interfere with treating it as a disease.
https://immattersacp.org/archives/2024/07/treating-obesity-as-a-disease.htm
1 Jul 2024
Diagnose, address cognitive impairment in heart failure patients, society says
A new scientific statement from the Heart Failure Society of America advises clinicians to be alert to clues such as difficulty with money or running out of medicine, among other recommendations.
https://immattersacp.org/weekly/archives/2024/03/19/4.htm
19 Mar 2024
Lifestyle, treatment changes for afib
A new atrial fibrillation guideline focuses on early rhythm control and lifestyle changes such as physical activity and weight loss to slow or disrupt the course of the disease.
https://immattersacp.org/archives/2024/09/lifestyle-treatment-changes-for-afib.htm
1 Sep 2024
Frailer heart failure patients less likely to receive guideline-recommended therapy
A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
https://immattersacp.org/weekly/archives/2023/06/20/4.htm
20 Jun 2023